GPCR — Structure Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- $4.07bn
- $3.28bn
- 50
- 25
- 87
- 54
Annual balance sheet for Structure Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 37.4 | 107 | 90.8 | 467 | 884 |
| Prepaid Expenses | |||||
| Total Current Assets | 38.4 | 109 | 93.1 | 474 | 891 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.277 | 1.79 | 1.29 | 8.36 | 7.01 |
| Other Long Term Assets | |||||
| Total Assets | 38.7 | 111 | 97.8 | 482 | 903 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.04 | 8.66 | 13 | 24.7 | 36 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.17 | 8.93 | 13 | 29.1 | 38.5 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 35.5 | 102 | 84.8 | 453 | 865 |
| Total Liabilities & Shareholders' Equity | 38.7 | 111 | 97.8 | 482 | 903 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |